Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
41.46
+3.50 (9.22%)
At close: Mar 27, 2026
Market Cap18.46B +2.7%
Revenue (ttm)1.56B -37.9%
Net Income-553.29M
EPS-1.29
Shares Out445.34M
PE Ration/a
Forward PE49.36
Dividendn/a
Ex-Dividend Daten/a
Volume6,356,858
Average Volume2,719,620
Open37.77
Previous Close37.96
Day's Range37.75 - 42.42
52-Week Range34.61 - 89.04
Beta0.85
RSI57.03
Earnings DateApr 23, 2026

About Sinocelltech Group

Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, and vaccines in China. The company offers Anjiayin, a third-generation recombinant coagulation factor VIII product for the treatment of hemophilia A; Anpingxi, an anti-CD20 monoclonal antibody for the treatment of CD20-positive diffuse large B-cell non-Hodgkin's lymphoma; Anjiarun, an adalimumab biosimilar for the treatment of various autoimmune diseases; Anbezu, a bevacizumab biosimilar for the ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,242
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements